Vaxcyte Sale Purchase Of Stock from 2010 to 2024

PCVX Stock  USD 86.53  0.32  0.37%   
Vaxcyte Sale Purchase Of Stock yearly trend continues to be fairly stable with very little volatility. Sale Purchase Of Stock will likely drop to about 1.9 M in 2024. During the period from 2010 to 2024, Vaxcyte Sale Purchase Of Stock regression line of annual values had r-squared of  0.57 and arithmetic mean of  30,937,340. View All Fundamentals
 
Sale Purchase Of Stock  
First Reported
2010-12-31
Previous Quarter
M
Current Value
1.9 M
Quarterly Volatility
22.2 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Vaxcyte financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Vaxcyte's main balance sheet or income statement drivers, such as Interest Income of 66.1 M, Interest Expense of 0.0 or Selling General Administrative of 63.7 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 5.16. Vaxcyte financial statements analysis is a perfect complement when working with Vaxcyte Valuation or Volatility modules.
  
Check out the analysis of Vaxcyte Correlation against competitors.
For more information on how to buy Vaxcyte Stock please use our How to Invest in Vaxcyte guide.

Latest Vaxcyte's Sale Purchase Of Stock Growth Pattern

Below is the plot of the Sale Purchase Of Stock of Vaxcyte over the last few years. It is Vaxcyte's Sale Purchase Of Stock historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Vaxcyte's overall financial position and show how it may be relating to other accounts over time.
Sale Purchase Of Stock10 Years Trend
Slightly volatile
   Sale Purchase Of Stock   
       Timeline  

Vaxcyte Sale Purchase Of Stock Regression Statistics

Arithmetic Mean30,937,340
Geometric Mean13,004,534
Coefficient Of Variation71.87
Mean Deviation19,789,013
Median44,047,000
Standard Deviation22,234,319
Sample Variance494.4T
Range62.1M
R-Value(0.75)
Mean Square Error229.9T
R-Squared0.57
Significance0
Slope(3,747,640)
Total Sum of Squares6921.1T

Vaxcyte Sale Purchase Of Stock History

20241.9 M
2023M
2022M
2021888 K
2020374 K
201942.9 M
201862.5 M

About Vaxcyte Financial Statements

Vaxcyte investors use historical fundamental indicators, such as Vaxcyte's Sale Purchase Of Stock, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Vaxcyte. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Sale Purchase Of StockM1.9 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Vaxcyte Stock Analysis

When running Vaxcyte's price analysis, check to measure Vaxcyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxcyte is operating at the current time. Most of Vaxcyte's value examination focuses on studying past and present price action to predict the probability of Vaxcyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxcyte's price. Additionally, you may evaluate how the addition of Vaxcyte to your portfolios can decrease your overall portfolio volatility.